173859NASDAQ: BGM

Profile

Sector:

Healthcare

Country:

China

IPO:

24 January 2003

Next earnings report:

15 November 2024

Last dividends:

27 February 2023

Next dividends:

N/A
$47.12 M
-62%vs. 3y high
34%vs. sector
-vs. 3y high
-vs. sector
-53%vs. 3y high
41%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Tue, 12 Nov 2024 14:30:00 GMT
$6.52-$0.49(-6.99%)
No data over the past 3 years
No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

Included in screeners

No data

What type of business is 173859?

BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.

What sector is 173859 in?

173859 is in the Healthcare sector

What industry is 173859 in?

173859 is in the Drug Manufacturers - Specialty & Generic industry

What country is 173859 from?

173859 is headquartered in China

When did 173859 go public?

173859 initial public offering (IPO) was on 24 January 2003

What is 173859 website?

https://www.bgm.ltd

Is 173859 in the S&P 500?

No, 173859 is not included in the S&P 500 index

Is 173859 in the NASDAQ 100?

No, 173859 is not included in the NASDAQ 100 index

Is 173859 in the Dow Jones?

No, 173859 is not included in the Dow Jones index

When was 173859 the previous earnings report?

No data

When does 173859 earnings report?

The next expected earnings date for 173859 is 15 November 2024